BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6124227)

  • 1. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma.
    Berrospi AR; Leibowitz HM
    Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP; Van Buskirk EM; Shields MB
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist.
    Feghali JG; Kaufman PL
    Am J Ophthalmol; 1985 Dec; 100(6):777-82. PubMed ID: 2866715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of betaxolol on primary open-angle glaucoma and normal-tension glaucoma patients.
    Saccà SC; Macrì A; Rolando M; Ciurlo G
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):191-201. PubMed ID: 9671427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group.
    Vogel R; Tipping R; Kulaga SF; Clineschmidt CM
    Arch Ophthalmol; 1989 Sep; 107(9):1303-7. PubMed ID: 2571326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
    Bleckmann H; Dorow P
    Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new beta-blockers for glaucoma.
    Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial experience with the beta-blocker befunolol in the treatment of open-angle glaucoma in Europe].
    Merté HJ; Stryz JR
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):55-8. PubMed ID: 6142975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of betaxolol and timolol on the venous tone in glaucoma patients.
    Bojic L; Bagatin J; Ivanisevic M; Hozo I; Racic G; Karelovic D
    Int Ophthalmol; 1999; 23(3):149-53. PubMed ID: 11456252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta adrenergic blocking agents for open-angle glaucoma.
    Lee ME
    J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
    Evans DW; Harris A; Cantor LB
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early visual field changes with beta-blocking agents.
    Collignon-Brach J
    Surv Ophthalmol; 1989 Apr; 33 Suppl():429-30; discussion 435-6. PubMed ID: 2568695
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma.
    Ikeda Y; Mori K; Ishibashi T; Naruse S; Nakajima N; Kinoshita S
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):230-4. PubMed ID: 18341431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betaxolol and levobunolol: new beta-blocking antiglaucoma agents.
    Tierney DW
    J Am Optom Assoc; 1987 Sep; 58(9):722-7. PubMed ID: 2895783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaxolol eye drops as a safe medication to lower intraocular pressure.
    Brooks AM; Gillies WE; West RH
    Aust N Z J Ophthalmol; 1987 May; 15(2):125-9. PubMed ID: 2887181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.